ArticleCells2019

Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement.

Ji-Hyun Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.